Shire PLC

SHPG-Q

NASDAQ:SHPG

0.00
0.00 (0.00%)
Shire Plc is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products include Vyvanse, Lialda, and Adderall XR.
More at Wikipedia

Analysis and Opinions about SHPG-Q

Signal
Opinion
Expert
TOP PICK
TOP PICK
April 18, 2017

A pharmaceutical/biotech company. It has an extremely attractive valuation, dirt cheap, trading at under 11X forward earnings. This has a really good stable of rare disease drugs that are very much untouched in the marketplace. The pharmaceutical sector has been absolutely beaten up and is becoming absolutely compelling. Dividend yield of 0.53%. (Analysts’ price target is £6100.)

Show full opinionHide full opinion
Shire PLC (SHPG-Q)
April 18, 2017

A pharmaceutical/biotech company. It has an extremely attractive valuation, dirt cheap, trading at under 11X forward earnings. This has a really good stable of rare disease drugs that are very much untouched in the marketplace. The pharmaceutical sector has been absolutely beaten up and is becoming absolutely compelling. Dividend yield of 0.53%. (Analysts’ price target is £6100.)

BUY
BUY
May 25, 2016

(Market Call Minute) He likes pharma and the more North American focus. Prefers JNJ-N but is okay with this one.

Show full opinionHide full opinion
Shire PLC (SHPG-Q)
May 25, 2016

(Market Call Minute) He likes pharma and the more North American focus. Prefers JNJ-N but is okay with this one.

PAST TOP PICK
PAST TOP PICK
February 4, 2013

(A Top Pick Feb 1/12. Up 2.18%.) Focused on special opportunities in the pharmaceutical world. Got under pressure because there were generics coming in on their key drugs but it turned out the risk wasn’t as threatening as the market had expected. Stock has been rallying lately.

Show full opinionHide full opinion
Shire PLC (SHPG-Q)
February 4, 2013

(A Top Pick Feb 1/12. Up 2.18%.) Focused on special opportunities in the pharmaceutical world. Got under pressure because there were generics coming in on their key drugs but it turned out the risk wasn’t as threatening as the market had expected. Stock has been rallying lately.

TOP PICK
TOP PICK
February 1, 2012
Irish pharmaceutical company and its major franchise is Adderall for attention deficit disorder. The opportunity here is that they can move it into adults. The other part of their business is orphan drugs, drugs that are not targets for large pharmaceuticals.
Show full opinionHide full opinion
Shire PLC (SHPG-Q)
February 1, 2012
Irish pharmaceutical company and its major franchise is Adderall for attention deficit disorder. The opportunity here is that they can move it into adults. The other part of their business is orphan drugs, drugs that are not targets for large pharmaceuticals.
TOP PICK
TOP PICK
November 9, 2006
(A Top Pick Jan 26/05. Up 11%.) Pharma company that’s moving into the biotech space. Have a lot of new products. Does $1.9 billion in revenues and can add another $1.4 billion incremental revenues in the next 4-5 years if the products are approved.
Show full opinionHide full opinion
Shire PLC (SHPG-Q)
November 9, 2006
(A Top Pick Jan 26/05. Up 11%.) Pharma company that’s moving into the biotech space. Have a lot of new products. Does $1.9 billion in revenues and can add another $1.4 billion incremental revenues in the next 4-5 years if the products are approved.
TOP PICK
TOP PICK
January 26, 2006
A UK company that does such nervous system pharmaceutical products. The big product is for hyperactive disorder. Adderall, a big seller, does not become generic for three years. Multiple in the high teens. Also has five new products coming out.
Show full opinionHide full opinion
Shire PLC (SHPG-Q)
January 26, 2006
A UK company that does such nervous system pharmaceutical products. The big product is for hyperactive disorder. Adderall, a big seller, does not become generic for three years. Multiple in the high teens. Also has five new products coming out.
Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

Shire PLC(SHPG-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Shire PLC is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Shire PLC(SHPG-Q) Frequently Asked Questions

What is Shire PLC stock symbol?

Shire PLC is a American stock, trading under the symbol SHPG-Q on the NASDAQ (SHPG). It is usually referred to as NASDAQ:SHPG or SHPG-Q

Is Shire PLC a buy or a sell?

In the last year, there was no coverage of Shire PLC published on Stockchase.

Is Shire PLC a good investment or a top pick?

Shire PLC was recommended as a Top Pick by John Stephenson on 2017-04-18. Read the latest stock experts ratings for Shire PLC.

Why is Shire PLC stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Shire PLC worth watching?

In the last year, there was no coverage of Shire PLC published on Stockchase.

What is Shire PLC stock price?

On , Shire PLC (SHPG-Q) stock closed at a price of $.